Study of Ipilimumab After Stem Cell Transplantation in People With Relapsed/Refractory Multiple Myeloma

NCT04635735 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
3
Enrollment
OTHER
Sponsor class

Stopped Lack of accrual

Conditions

Interventions

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators